Infertility
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 35 to 43 who underwent IVF/ICSI-ET treatment due to infertility; 2. Meeting the criteria for Poseidon Group 4 of diminished ovarian reserve (AFC < 5, AMH < 1.2 ng/ml); 3. 18.5kg/m^2<=Body Mass Index (BMI)<28 kg/m^2; 4. Full understanding of the study content, voluntary participation, and provision of signed written informed consent.
Exclusion criteria
Exclusion criteria: 1.Those with uncontrollable medical diseases that may interfere with or affect the research results, such as serious liver, kidney, heart, brain diseases; 2.Taking other micronutrients, hormones or other drugs that affect fertility except folic acid within one month; 3.Diagnosis of uncontrolled endocrine or metabolic disorders (e.g., thyroid dysfunction, diabetes mellitus, hyperprolactinemia); 4.Known allergy or hypersensitivity to the investigational products (taurine, Coenzyme Q10) or their excipients; 5. Those who failed to return for follow-up appointments on time, had incomplete medical records, and were lost to follow-up for various reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of day 3 high-quality embryos; | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of oocytes retrieved ;Number of MII oocytes;Number of fertilized oocytes (2PN);Number of day 3 available embryos;anti-Müllerian hormone;Biochemical pregnancy;Clinical pregnancy;Early abortion; | — |
Countries
China
Contacts
the 901th Hospital of the Joint logistics support Force of People’s Liberation Army